All Lab Notes

The creative debate around AI is loud, but the advantage is being built quietly. When analysing Substack's AI usage survey , one line kept landing harder than the rest: It isn't a fight about "ethics" vs "authenticity". It's a mindset split, and it's already changing who wins. Some creatives are treating AI like a contamination risk. Others are treating it like a sparring partner, and compounding skill fast. That's the part people miss. What the survey actually revealed (in

The global mood around AI in healthcare is confident and ambitious, but quietly uneasy. At the World Economic Forum in Davos, political and business leaders warned that artificial intelligence is moving faster than institutions’ ability to govern it, with trust, not intelligence, emerging as the real constraint on adoption. In the Gulf, that caution sits alongside aggressive investment. Dubai-based companies are launching AI-driven platforms in drug discovery and diagnost

AI agents are no longer speculative technologies relegated to R&D labs or sci-fi headlines. They’ve crossed the threshold into strategic corporate infrastructure. As enterprises enter 2026, the era of agentic systems reshaping workflows, decisions, and outcomes is no longer future talk. Yet, a surprising number of product teams still pitch agents as cool capabilities instead of C-suite investments with tangible financial impact . Let’s be clear: CEOs aren’t interested in fe